Drug Profile
LY 3079514
Alternative Names: LY3079514Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Undefined(In volunteers) in USA (IV, Infusion)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Undefined(In volunteers) in USA (SC, Injection)
- 01 Oct 2014 Phase-I clinical trials in Undefined indication (In volunteers) in USA (IV)